Integral Derivatives’s Merck MRK Stock Holding History

Integral Derivatives’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$953K	Sell	18,340 -22,113	-55%	-$1.19M	0.02%	246
2017 Q4	$2.17M	Buy	40,453 +8,908	+28%	+$494K	0.04%	273
2017 Q3	$1.93M	Sell	31,545 -24,418	-44%	-$1.48M	0.04%	322
2017 Q2	$3.42M	Buy	55,963 +11,213	+25%	+$683K	0.07%	176
2017 Q1	$2.71M	Buy	44,750 +734	+2%	+$44.5K	0.05%	241
2016 Q4	$2.47M	Buy	44,016 +29,030	+194%	+$1.7M	0.05%	270
2016 Q3	$892K	Sell	14,986 -20,960	-58%	-$1.23M	0.02%	459
2016 Q2	$1.98M	Buy	35,946 +13,624	+61%	+$725K	0.05%	241
2016 Q1	$1.13M	Sell	22,322 -37,938	-63%	-$1.86M	0.04%	350
2015 Q4	$3.04M	Buy	60,260 +4,192	+7%	+$211K	0.08%	192
2015 Q3	$2.64M	Buy	56,068 +41,501	+285%	+$2.2M	0.07%	237
2015 Q2	$791K	Sell	14,567 -21,799	-60%	-$1.22M	0.02%	595
2015 Q1	$2M	Sell	36,366 -30,496	-46%	-$1.73M	0.04%	293
2014 Q4	$3.62M	Buy	66,862 +48,522	+265%	+$2.7M	0.06%	262
2014 Q3	$1.04M	Sell	18,340 -12,262	-40%	-$689K	0.02%	694
2014 Q2	$1.69M	Sell	30,602 -5,659	-16%	-$309K	0.03%	490
2014 Q1	$1.96M	Sell	36,261 -27,667	-43%	-$1.43M	0.04%	417
2013 Q4	$3.05M	Buy	+63,928	New	+$2.92M	0.04%	360

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Integral Derivatives's MRK Position: Q1 2018 in Review

Integral Derivatives opened a new position in Merck (MRK) in Q1 2018: 15,785 shares worth $820K. The stake represents 0.02% of the portfolio and ranks #289 among its holdings. This is a return to the name: Integral Derivatives previously reported a position in MRK as recently as Q3 2017.

Integral Derivatives first reported a position in MRK in Q1 2014 and has held it in 12 quarters since. The position peaked at $2.69M in Q2 2014. 1,992 funds tracked by Wall St. Rank hold MRK as of Q1 2018.

Integral Derivatives held 15,785 shares of Merck worth $820K as of Q1 2018.
Merck was a new Integral Derivatives position in Q1 2018.
Merck made up 0.02% of Integral Derivatives's portfolio in Q1 2018, its #289 holding.
Integral Derivatives first reported a position in Merck in Q1 2014 and has held it in 12 quarters since.
Integral Derivatives's Merck position peaked at $2.69M in Q2 2014.
1,992 funds tracked by Wall St. Rank held Merck as of Q1 2018.

Based on Integral Derivatives's 13F filing for Q1 2018, filed 19 Apr 2018.